TCON
TRACON Pharmaceuticals, Inc. Common Stock
TCON
TCON
Delisted
TCON was delisted on the 27th of June, 2024.
35 hedge funds and large institutions have $24M invested in TRACON Pharmaceuticals, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 10 increasing their positions, 7 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
5% less capital invested
Capital invested by funds: $25.4M → $24M (-$1.35M)
Holders
35
Holding in Top 10
1
Calls
$748K
Puts
$80K
Top Buyers
| 1 | +$449K | |
| 2 | +$400K | |
| 3 | +$263K | |
| 4 |
Bank of New York Mellon
New York
|
+$150K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$73.6K |
Top Sellers
| 1 | -$479K | |
| 2 | -$324K | |
| 3 | -$310K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$263K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$55K |